The fact that ACL will be derisked ........not spilling 20...

The fact that ACL will be derisked ........not spilling 20 million a year on oncology trials etc, to my way of thinking is a huge plus and many shareholders and future investors in this stock may view it as a plus also. It sort of negates the fact that the company is splitting. We will be a company with a substantial revenue stream without too much outgoing expense.I wouldn't be surprised if after the next Fonda announcement that we retain a share price of what we have presently.. We may and probably will contract slightly but I reckon that any contraction will be short lived. I agree with Mr Dog 's analysis. Audeo rumours are that we are in for the ride of our lives, Pete reckons this is going to go "gangbusters" on Nasdaq . Mr Dog , if you are attending the meeting tomorrow, I will meet you at the coffee shop downstairs at 9.35